Nathalie Adda, Senior VP & Chief Medical Officer at ENANTA PHARMACEUTICALS INC (ENTA), sold 4,225 shares at $85.11 ($362K) on 2018-04-16, disclosed to the SEC on 2018-04-18.
Open-market sale of $362k ENTA by Senior VP & Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.11 | 1,800 | $153K | 42.4% |
| 2 | $85.92 | 2,425 | $208K | 57.6% |
| Total | $85.57 avg | 4,225 | $362K | 100% |
| Filing → |
| ENTA | SELL | 2022-01-13 | $1.8M | — | Filing → |
| ENTA | SELL | 2021-12-03 | $1.9M | — | Filing → |
| ENTA | SELL | 2021-11-02 | $1.6M | — | Filing → |